BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33455121)

  • 1. Baseline characteristics of a nationwide cohort of pediatric patients with acute leukemias of Down syndrome.
    Sas V; Blag C; Pasca S; Popa G; Marian M; Schnell C; Voda D; Arghirescu ST; Teodorescu P; Iluta S; Turcas C; Selicean C; Bojan A; Zdrenghea M; Serban M; Dima D; Zaharie G; Colita A; Man S; Tomuleasa C
    J BUON; 2020; 25(6):2737-2746. PubMed ID: 33455121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematological disorders and leukemia in children with Down syndrome.
    Bruwier A; Chantrain CF
    Eur J Pediatr; 2012 Sep; 171(9):1301-7. PubMed ID: 22113227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematological disorders in children with Down syndrome.
    Triarico S; Trombatore G; Capozza MA; Romano A; Mastrangelo S; Attinà G; Maurizi P; Ruggiero A
    Expert Rev Hematol; 2022 Feb; 15(2):127-135. PubMed ID: 35184659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.
    Lam GK; Leung AW; Ha SY; Luk CW; Li CH; Ling SC; Chiang AK; Li CK
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):102-6. PubMed ID: 26808367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient leukemia of Down syndrome.
    Sas V; Blag C; Zaharie G; Puscas E; Lisencu C; Andronic-Gorcea N; Pasca S; Petrushev B; Chis I; Marian M; Dima D; Teodorescu P; Iluta S; Zdrenghea M; Berindan-Neagoe I; Popa G; Man S; Colita A; Stefan C; Kojima S; Tomuleasa C
    Crit Rev Clin Lab Sci; 2019 Jun; 56(4):247-259. PubMed ID: 31043105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Acute Leukemia among Children with Down Syndrome in Korea.
    Choi YB; Yoo KH
    Cancer Res Treat; 2022 Apr; 54(2):572-578. PubMed ID: 34384014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.
    Forestier E; Izraeli S; Beverloo B; Haas O; Pession A; Michalová K; Stark B; Harrison CJ; Teigler-Schlegel A; Johansson B
    Blood; 2008 Feb; 111(3):1575-83. PubMed ID: 17971484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute nonlymphocytic leukemia after transient myeloproliferative disorder in a patient with Down syndrome.
    Barnett PL; Clark AC; Garson OM
    Med Pediatr Oncol; 1990; 18(5):347-53. PubMed ID: 2142749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute leukemias in children with Down syndrome.
    Zwaan CM; Reinhardt D; Hitzler J; Vyas P
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):19-34. PubMed ID: 20113894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
    D'Angelo G; Merlo P
    Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and survival of children with acute leukemia with Down syndrome or other birth defects in New York State.
    Qiao B; Austin AA; Schymura MJ; Browne ML
    Cancer Epidemiol; 2018 Dec; 57():68-73. PubMed ID: 30326394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
    Zwaan CM; Kaspers GJ; Pieters R; Hählen K; Janka-Schaub GE; van Zantwijk CH; Huismans DR; de Vries E; Rots MG; Peters GJ; Jansen G; Creutzig U; Veerman AJ
    Blood; 2002 Jan; 99(1):245-51. PubMed ID: 11756178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group.
    Schultz KA; Chen L; Kunin-Batson A; Chen Z; Woods WG; Gamis A; Kawashima T; Oeffinger KC; Nicholson HS; Neglia JP
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):20-25. PubMed ID: 27906794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498.
    Ravindranath Y; Abella E; Krischer JP; Wiley J; Inoue S; Harris M; Chauvenet A; Alvarado CS; Dubowy R; Ritchey AK
    Blood; 1992 Nov; 80(9):2210-4. PubMed ID: 1384797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
    Brink DS
    Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-155-5p Plays a Critical Role in Transient Leukemia of Down Syndrome by Targeting Tumor Necrosis Factor Receptor Superfamily Members.
    Sas V; Pasca S; Jurj A; Pop L; Muramatsu H; Ono H; Dima D; Teodorescu P; Iluta S; Turcas C; Onaciu A; Munteanu R; Zimta AA; Blag C; Popa G; von Gamm EDA; Arghirescu S; Serban M; Man S; Marian M; Petrushev B; Berce C; Colita A; Zdrenghea M; Kojima S; Gulei D; Takahashi Y; Tomuleasa C
    Cell Physiol Biochem; 2020 Oct; 54(5):994-1012. PubMed ID: 33006449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
    Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
    J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment results in children with myeloid leukemia of Down syndrome in Saudi Arabia: A multicenter SAPHOS leukemia group study.
    Jastaniah W; Alsultan A; Al Daama S; Ballourah W; Bayoumy M; Al-Anzi F; Al Shareef O; Abrar MB; Al Sudairy R; Al Ghemlas I
    Leuk Res; 2017 Jul; 58():48-54. PubMed ID: 28445808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological disturbances in Down syndrome: single centre experience of thirteen years and review of the literature.
    Karakurt N; Uslu İ; Aygün C; Albayrak C
    Turk J Pediatr; 2019; 61(5):664-670. PubMed ID: 32104997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.